Inovio Pharma (INO) Reports Q1 Loss of $0.30/Share
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $10.13 -0.3%
EPS Growth %: -625.0%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: -625.0%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q1 EPS of ($0.30), versus ($0.36) reported last year. Revenue for the quarter came in at $2.83 million, versus $1.53 million reported last year.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- COPT Defense Properties (CDP) Reports In-Line Q1 EPS; offers guidance
- AptarGroup (ATR) Tops Q1 EPS by 11c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
